spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

SMI Immuno-Oncology Conference

25-27 September 2018
Copthorne Tara Hotel, London, UK

Immuno-Oncology is a fast-paced field with massive potential to deliver successful and durable cancer therapies, and SMi's Immuno-Oncology Conference will focus on a few key areas of the field with a representation of the whole industry under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.

At the SMi's Immuno-Oncology Conference participants will get:

Agenda: Valuable time is spent to discover the latest trends and hottest topics in the industry to provide the best possible agenda for our attendees. 15+ engaging presentations/case studies/keynote addresses, including:

  • Targeting immune checkpoints with Humabody VH therapeutics by James Legg of Crescendo Biologics
  • Keytruda: anticancer therapy across a wide range of malignancies by Kandeepan Ganeshalingam of Merck Sharp & Dohme Limited
  • Human tissue research in the UK: ethics and regulation by Christopher Perrett of Human Tissue Authority

Speakers: Top representation of industry leaders. 15+ leading experts in Immuno-Oncology field, including;

  • Grace Macaulay, Global Safety Physician, Patient Safety-Oncology, MedImmune
  • Harry Smith, Medical Scientist, Gilead
  • Jonathan Zalevsky, Senior Vice President Biology & Preclinical Development, Nektar Therapeutics
  • Rochana Wickramasinghe, Evaluation Director, AstraZeneca

Workshops: Carefully selected topics for further on-sight training. 2 pre-conference workshops with in-depth knowledge on specific topics:

  • Strategic Competitive Intelligence in the Immuno-Oncology space - hosted by LucidQuest Ventures
  • Could the Microbiome boost Cancer Immuno-Therapy - hosted by ImmuneBiotech and Lund University

Networking: Networking is at the forefront of SMi events. 5+ hours of pure networking guaranteed. Follow event updates to be in the know about who will be joining the conversation.

To View detailed information about event programme, speaker line-up and workshop agenda visit http://www.immuno-oncology-conference.com/SMDWL 

Twitter - @SMIpharm & #immunooncologysmi

LinkedIn - SMi Pharma

CONTACT:

+44 (0)20 7827 6000

ldurneva@smi-online.co.uk

 
Print this page
Send to a friend
   
spacer
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

White Papers

Mauritius Island – An Emerging Centre for R&D in Biotechnology and the Life Sciences

CIDP (Centre International de Développement Pharmaceutique)

Mauritius, the tropical island situated in the Indian Ocean and known worldwide for its beautiful beaches, is also internationally recognised for its rule of law, and political and social stability. Over the past few years, the economy has been successfully transitioned from a monocrop to a diversified innovation-driven and knowledge-based economy, resting on agribusiness, export-oriented manufacturing, tourism, financial services, property development and real estate, ICT-BPO, the seafood industry, a free port, logistics and a nascent ocean economy. Emerging sectors such as healthcare and life sciences are presenting some niche areas for the taking, and the enabling environment is being put in place to make it happen - especially in the light of sustained growth within pharmaceutical, medical device, and clinical research. Important international players are already in operation locally as the country has established the appropriate legal and regulatory frameworks based on international norms, for the development of a strong biomedical research sector.
More info >>


News and Press Releases

Signant Health Appoints Ian Jennings as Chief Commercial Officer

PHILADELPHIA, PA – March 4, 2020: Signant Health is proud to announce the appointment of Ian Jennings as Chief Commercial Officer to help support the next phase of Signant Health’s growth as a leading advocate of patient focused technology solutions.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement